THE EDINBURGH INVESTMENT TRUST PLC 41 b Analysis of investments gains 2013 2012 000 000 Opening book cost 954,023 957,704 Opening investment holding gains 221,052 130,774 Opening valuation 1,175,075 1,088,478 Movements in year: Purchases at cost 149,276 112,053 Sales proceeds 168,644 135,378 net realised gains on sales 25,437 19,644 Movement in investment holding gains 159,804 90,278 Closing valuation 1,340,948 1,175,075 Closing book cost 960,092 954,023 Closing investment holding gains 380,856 221,052 Closing valuation 1,340,948 1,175,075 There were no purchases or sales of unlisted investments during the year 2012: nil.
c Gains on investments 2013 2012 000 000 Realised gains on sales 25,437 19,644 Movement in investment holding gains 159,804 90,278 Gains on investments 185,241 109,922 d Transaction costs Transaction costs on purchases of 886,000 2012: 518,000 and on sales of 221,000 2012: 143,000 are included within gains and losses on investments.
e Significant holdings At 31 March 2013 the Company had holdings of 3% or more of the number in issue of the following investments: Name of undertaking Country of Incorporation Instrument % held Oxford Pharmascience England & Wales Ordinary shares 5.0 Barclays Bank England & Wales Nuclear Power Notes 28 February 2019 4.4 Raven Russia Guernsey Preference shares 3.0 10.
Debtors 2013 2012 000 000 Amounts due from brokers 2,888 Prepayments and accrued income 7,125 6,912 Unrealised profit on forward currency contracts 617 103 Tax recoverable 1,668 1,496 9,410 11,399
